mesalamine has been researched along with valganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aggarwal, D; Chakraborty, S; Yadav, L | 1 |
1 review(s) available for mesalamine and valganciclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for mesalamine and valganciclovir
| Article | Year |
|---|---|
Prediction of in vivo drug performance using in vitro dissolution coupled with STELLA: a study with selected drug products.
Topics: Capsules; Computer Simulation; Drug Liberation; Ganciclovir; Humans; Linezolid; Mesalamine; Models, Biological; Solubility; Tablets; Tacrolimus; Valganciclovir | 2015 |